[Effects of concomitant drugs on the blood concentration of a histamine H2 antagonist (1st report). Oral administration of ranitidine together with high doses of neutralizing antacid and sucralfate].
D000284:Administration, Oral; D000328:Adult; D000535:Aluminum / Q000008:administration & dosage*; D000536:Aluminum Hydroxide / Q000008:administration & dosage*; D000863:Antacids / Q000008:administration & dosage*; D004338:Drug Combinations / Q000008:administration & dosage; D005215:Fasting; D006801:Humans; D007700:Kinetics; D008274:Magnesium / Q000008:administration & dosage*; D008276:Magnesium Hydroxide / Q000008:administration & dosage*; D008297:Male; D011899:Ranitidine / Q000008:administration & dosage / Q000097:blood*; D013392:Sucralfate
D000863:Antacids; D004338:Drug Combinations; C013591:aluminum hydroxide, magnesium hydroxide, drug combination; D013392:Sucralfate; D000536:Aluminum Hydroxide; D011899:Ranitidine; D000535:Aluminum; D008274:Magnesium; D008276:Magnesium Hydroxide